FDA approves Moderna’s mRNA flu vaccine for older adults
The Food and Drug Administration has approved Moderna’s mFLUSIVA, the first mRNA based flu vaccine, for adults 50 and older. The vaccine relies on the same mRNA technology used in the company’s COVID-19 vaccine, marking a new direction in seasonal flu prevention for a population at higher risk of serious complications. What mFLUSIVA is mFLUSIVA, […]